0001628280-23-034579.txt : 20231018
0001628280-23-034579.hdr.sgml : 20231018
20231018160234
ACCESSION NUMBER: 0001628280-23-034579
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231016
FILED AS OF DATE: 20231018
DATE AS OF CHANGE: 20231018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woods Keith
CENTRAL INDEX KEY: 0001996804
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38295
FILM NUMBER: 231332239
MAIL ADDRESS:
STREET 1: C/O X4 PHARMACEUTICALS INC.
STREET 2: 61 NORTH BEACON STREET 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
BUSINESS PHONE: 857-529-8300
MAIL ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
FORMER COMPANY:
FORMER CONFORMED NAME: Arsanis, Inc.
DATE OF NAME CHANGE: 20100920
4
1
wk-form4_1697659344.xml
FORM 4
X0508
4
2023-10-16
0
0001501697
X4 Pharmaceuticals, Inc
XFOR
0001996804
Woods Keith
C/O X4 PHARMACEUTICALS INC.
61 NORTH BEACON STREET 4TH FLOOR
BOSTON
MA
02134
1
0
0
0
0
Common Stock
2023-10-16
4
A
0
90000
0
A
90000
D
Represents a restricted stock units ("RSUs") grant. The RSUs will vest in three equal annual installments commencing on October 16, 2024, subject to the Reporting Person's continued service as a director through each such date.
/s/ Adam S. Mostafa, attorney-in-fact
2023-10-18